"10.1371_journal.pone.0095164","plos one","2014-04-21T00:00:00Z","Fiona P Havers; Barbara Detrick; Sandra W Cardoso; Sima Berendes; Javier R Lama; Patcharaphan Sugandhavesa; Noluthando H Mwelase; Thomas B Campbell; Amita Gupta; for the ACTG A5175 PEARLS and NWCS319 Study Teams","Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America; Evandro Chagas Clinical Research Institute (IPEC), FIOCRUZ, Rio de Janeiro, Brazil; College of Medicine-Johns Hopkins University Research Project, Blantyre, Malawi; Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Asociacion Civil Impacta Salud y Educacion, Lima, Peru; Chiang Mai University, Chiang Mai, Thailand; University of Witswatersrand, Johannesburg, South Africa; University of Colorado Denver, Aurora, Colorado, United States of America","Â¶ Membership of the ACTG A5175 PEARLS study and NWCS 319 Study Teams is provided in the Acknowledgments.","The authors have the following interests: This research was supported in part by Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, and GlaxoSmithKline. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","04","Fiona P Havers","FPH",10,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
